Medical Xpress October 23, 2024
Katherine Egan Bennett, University of Texas at Arlington

Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools. For problems in the genitourinary (GU) tract (which includes the kidneys, prostate, and bladder), health providers usually use a combination of screening tools, including blood tests, imaging, and physical examinations. Scientists are now working on an even simpler tool for screening illnesses before they become a problem—urine analysis.

According to a study from scientists at The University of Texas at Arlington, Chan-Zuckerberg Biohub, and Stanford University, studying the RNA (a type of genetic material) and other substances within urine can show changes in , revealing early signs of cancer and other diseases. This method could help clinicians detect...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article